+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily



Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily



British Journal of Clinical Pharmacology 19(Suppl. 2): 207s-212s



Nineteen patients receiving oxprenolol slow-release (SR) 160 mg (three patients) or 320 mg (16 patients) once daily for mild to moderate hypertension were treated with oxprenolol Oros 16/260 once daily for 3 weeks following a 2 week placebo wash-out period. Repeated dosing with both Oros and SR oxprenolol preparations, in comparison with placebo, significantly reduced supine systolic and diastolic blood pressures, and pulse rate at 24 h after dosing. Single Oros doses also significantly reduced pulse rate and diastolic, but not systolic, blood pressure at 24 h. The reduction in supine systolic blood pressure was greater during repeated dosing with oxprenolol SR than after a single dose of the Oros preparation. Control of supine diastolic blood pressure (less than or equal to 90 mm Hg) at 24 h after dosing was achieved in 13 out of 18 patients with oxprenolol SR (two out of three patients given 160 mg, and 11 out of 15 given 320 mg). Similar control was achieved in 11 out of 18 patients after a single dose of oxprenolol Oros, and in 13 out of 17 patients treated for 3 weeks. The mean percentage reduction in exercise heart rate (EHR) compared to placebo, at 24 h after dosing, was 16% following Oros treatment for 3 weeks, and 12% following SR administration. After a single dose of oxprenolol Oros EHR, was reduced by 9% at 24 h compared to placebo. At 3 weeks the Oros formulation was significantly better than the SR tablet at reducing EHR. Oxprenolol Oros 16/260 was effective over 24 h and well tolerated.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040087927

Download citation: RISBibTeXText

PMID: 4005124

DOI: 10.1111/j.1365-2125.1985.tb02764.x


Related references

Exercise and resting blood pressure and heart rate changes 24 hours after dosing in patients with essential hypertension receiving 16 260 oxprenolol oros once daily. British Journal of Clinical Pharmacology 19(Suppl. 2): 207S-212S, 1985

Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion. European Journal of Clinical Pharmacology 30(4): 399-406, 1986

Effect of oxprenolol vs. nifedipine on resting and exercise blood pressure in essential hypertension. Clinica Terapeutica 124(3): 203-210, 1988

The acute and chronic effects of oxprenolol on ambulatory blood pressure and heart rate in essential hypertension. British Journal of Clinical Pharmacology 8(4): 389p, 1979

Evaluation of arterial blood pressure and heart rate during exercise tests in patients with essential hypertension in different stages of hypertension. Polskie Archiwum Medycyny Wewnetrznej 95(4): 323-332, 1996

Pre-dosing plasma concentrations and beta-adrenoceptor blocking effects during repeated once daily dosing with 160 mg sustained-release propranolol (Inderal LA) and 16/260 oxprenolol Oros to healthy volunteers. British Journal of Clinical Pharmacology 19(Suppl. 2): 197s-201s, 1985

Blood pressure values in hypertensive patients The relationship of resting and exercise blood pressure in subjects with essential hypertension before and after drug treatment with propranolol. Heart & Lung 21(6): 509-514, 1992

The effects of metoprolol and celiprolol on resting systolic blood pressure , resting heart rate , exercise heart rate , aortic blood peak acceleration and velocity and finger tremor. Clinical Pharmacology & Therapeutics 53(2): 143, 1993

Pre dosing plasma concentrations and beta adrenoceptor blocking effects during repeated once daily dosing with 160 milligram sustained release propranolol inderal la and 16 260 oxprenolol oros to healthy volunteers. British Journal of Clinical Pharmacology 19(Suppl. 2): 197S-202S, 1985

Effects of fosenopril, a once-daily angiotensin-converting enzyme inhibitor, on resting and exercise-induced changes of blood pressure, hormonal variables, and plasma potassium in essential hypertension. American Journal of Hypertension 1(3 Pt 3): 280s-283s, 1988

Comparison of the acute effects of acebutolol and propranolol on blood pressure, heart rate and hormonal changes during graded treadmill exercise in patients with essential hypertension. Japanese Journal of Medicine 28(1): 8-15, 1989

Evaluation of two oxprenolol oral osmotic (OROS) delivery systems in patients with essential hypertension. European Journal of Clinical Pharmacology 34(6): 605-611, 1988

Comparison of the effects of oxprenolol and nifedipine on blood pressure at rest and during physical exercise in essential hypertension. La Clinica Terapeutica 124(3): 203-210, 1988

The effects of a 10-week water aerobic exercise on the resting blood pressure in patients with essential hypertension. Asian Journal of Sports Medicine 1(3): 159-167, 2010

Is exercise blood pressure a better predictor than resting blood pressure for target organ damage in essential hypertension. Journal of Hypertension 7(Suppl. 6): S362, 1989